Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
  1. 4 Grant or award Chief Medical Officer acquired 26,900 shares (grant or award)
  2. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 26,900 shares (grant or award)
  3. 4 Grant or award PRESIDENT AND CEO acquired 80,750 shares (grant or award)
  4. 4 Grant or award Chief Operating Officer acquired 26,900 shares (grant or award)
  5. 4 Planned sale PRESIDENT AND CEO sold 17,500 shares at an average $41.74 ($730,535)
  6. 4 Planned sale PRESIDENT AND CEO sold 17,500 shares at an average $43.07 ($753,680)
  7. 4 Planned sale PRESIDENT AND CEO sold 17,500 shares at an average $46.94 ($821,523)
  8. 4 Planned sale PRESIDENT AND CEO sold 19,375 shares at an average $47.98 ($929,560)
  9. 4 Grant or award Chief Legal Officer acquired 53,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Planned sale PRESIDENT AND CEO sold 30,625 shares at an average $49.50 ($1,516,037)
  12. 4 Planned sale Director sold 15,000 shares at an average $48.03 ($720,493)
  13. 4 Planned sale PRESIDENT AND CEO sold 19,375 shares at an average $40.39 ($782,610)
  14. 4 Planned sale PRESIDENT AND CEO sold 15,625 shares at an average $38.24 ($597,568)
  15. 4 Planned sale PRESIDENT AND CEO sold 23,125 shares at an average $46.05 ($1,064,809)
  16. 4 Planned sale Director sold 16,476 shares at an average $42.26 ($696,233)
  17. 4 Planned sale PRESIDENT AND CEO sold 15,625 shares at an average $37.50 ($585,934)
  18. 4 Planned sale PRESIDENT AND CEO sold 30,320 shares at an average $36.84 ($1,117,140)
  19. 4 Open-market sale PRESIDENT AND CEO sold 14,471 shares at $39.76 ($575,425)
  20. 4 Planned sale PRESIDENT AND CEO sold 15,625 shares at $37.56 ($586,927)

Page 4 of 12 · 230 filings